Is AUPH or IMNM more profitable?

AUPH runs the higher net margin — AUPH at 100.84% versus IMNM at -3059.99%.

How have AUPH and IMNM total returns compared?

Over the past 5 years, AUPH delivered -5.88% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.

Aurinia Pharmaceuticals Inc. (AUPH) vs Immunome, Inc. (IMNM)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AUPH

Aurinia Pharmaceuticals Inc.

$2.03B

$15.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

IMNM

Immunome, Inc.

$2.04B

$21.35HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — AUPH vs IMNM

growth of $100 · dividends reinvested · last 6y

AUPH +7.5% (+1.2%/yr)IMNM +57.4% (+7.9%/yr)IMNM compounded faster over this window

AUPH IMNM

AUPH vs IMNM: by the numbers

•IMNM is the larger company ($2.04B vs $2.03B market cap).
•AUPH is profitable (100.84% net margin) while IMNM runs a net loss (-3059.99%).

Metrics side by side

Valuation

Metric	AUPH	IMNM
P/E ratio	6.89	N/A
Forward P/E	16.71	N/A
P/S ratio	6.51	N/A
P/B ratio	3.30	3.89
EV / EBITDA	11.22	N/A
FCF yield	8.56%	N/A

Profitability

Metric	AUPH	IMNM
Gross margin	90.36%	57.43%
Operating margin	37.06%	-3084.76%
Net margin	100.84%	-3059.99%
ROE	51.09%	-48.43%
ROIC	21.77%	-51.06%

Growth (annualized)

Metric	AUPH	IMNM
Revenue CAGR (5Y)	40.17%	N/A
Total return CAGR (5Y)	-5.88%	2.88%

Frequently asked

Is AUPH or IMNM more profitable?: AUPH runs the higher net margin — AUPH at 100.84% versus IMNM at -3059.99%.
How have AUPH and IMNM total returns compared?: Over the past 5 years, AUPH delivered -5.88% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysis Full IMNM analysis Interactive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratio Aurinia Pharmaceuticals ROE Immunome ROE Aurinia Pharmaceuticals operating margin Immunome operating margin Aurinia Pharmaceuticals revenue growth Immunome revenue growth Aurinia Pharmaceuticals free cash flow Immunome free cash flow

Aurinia Pharmaceuticals & Immunome appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.